Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Intestinal absorption of captopril and two thioester analogs in rats and dogs.

Morrison RA, Kripalani KJ, Marino AM, Dean AV, Migdalof BH, Weinstein SH, Jain NB, Bathala MS, Singhvi SM.

Biopharm Drug Dispos. 1997 Jan;18(1):25-39.

PMID:
9008267
2.

Biotransformation of pravastatin sodium in humans.

Everett DW, Chando TJ, Didonato GC, Singhvi SM, Pan HY, Weinstein SH.

Drug Metab Dispos. 1991 Jul-Aug;19(4):740-8.

PMID:
1680649
3.

Disposition of zofenopril calcium in healthy subjects.

Singhvi SM, Foley JE, Willard DA, Morrison RA.

J Pharm Sci. 1990 Nov;79(11):970-3.

PMID:
2292772
4.
5.

Disposition of pravastatin sodium, a tissue-selective HMG-CoA reductase inhibitor, in healthy subjects.

Singhvi SM, Pan HY, Morrison RA, Willard DA.

Br J Clin Pharmacol. 1990 Feb;29(2):239-43.

6.
7.

Dose proportionality of nadolol pharmacokinetics after intravenous administration to healthy subjects.

Morrison RA, Singhvi SM, Creasey WA, Willard DA.

Eur J Clin Pharmacol. 1988;33(6):625-8.

PMID:
3366166
8.

Pharmacokinetics of intravenous captopril in healthy men.

Creasey WA, Morrison RA, Singhvi SM, Willard DA.

Eur J Clin Pharmacol. 1988;35(4):367-70.

PMID:
3058486
9.

Disposition of fosinopril sodium in healthy subjects.

Singhvi SM, Duchin KL, Morrison RA, Willard DA, Everett DW, Frantz M.

Br J Clin Pharmacol. 1988 Jan;25(1):9-15.

10.

Relationship between metabolism and pharmacologic activity of SQ 27,786, an angiotensin converting enzyme inhibitor with potent diuretic activity.

Everett DW, Singhvi SM, DeForrest JM, Morrison RA, Weinstein SH, Migdalof BH.

Drug Des Deliv. 1987 Sep;2(1):23-34.

PMID:
3509342
11.

Application of pharmacokinetics in drug safety evaluation.

Singhvi SM, Keim GR, Migdalof BH.

Regul Toxicol Pharmacol. 1985 Mar;5(1):3-17.

PMID:
3991931
12.

Tissue distribution of 14C- and 35S-captopril in rats after intravenous and oral administration.

Heald AF, Ita CE, Singhvi SM, Migdalof BH.

Xenobiotica. 1985 Jan;15(1):51-6.

PMID:
3885586
13.

Distribution of aztreonam into fetuses and milk of rats.

Singhvi SM, Ita CE, Shaw JM, Keim GR, Migdalof BH.

Antimicrob Agents Chemother. 1984 Aug;26(2):132-5.

14.

Distribution of [14C]aztreonam in rat tissue.

Singhvi SM, Ita CE, Shaw JM, Migdalof BH.

Antimicrob Agents Chemother. 1984 Aug;26(2):127-31.

15.

Disposition of [14C]aztreonam in rats, dogs, and monkeys.

Kripalani KJ, Singhvi SM, Weinstein SH, Everett DW, Bathala MS, Dean AV, Ita CE, Lawrence L, Meeker FS Jr, Shaw JM, et al.

Antimicrob Agents Chemother. 1984 Aug;26(2):119-26.

16.

Elimination kinetics of captopril in patients with renal failure.

Duchin KL, Pierides AM, Heald A, Singhvi SM, Rommel AJ.

Kidney Int. 1984 Jun;25(6):942-7.

17.

Quantitative determination of captopril in blood and captopril and its disulfide metabolites in plasma by gas chromatography.

Bathala MS, Weinstein SH, Meeker FS Jr, Singhvi SM, Migdalof BH.

J Pharm Sci. 1984 Mar;73(3):340-4.

PMID:
6371216
18.

Captopril: pharmacology, metabolism and disposition.

Migdalof BH, Antonaccio MJ, McKinstry DN, Singhvi SM, Lan SJ, Egli P, Kripalani KJ.

Drug Metab Rev. 1984;15(4):841-69. Review.

PMID:
6437780
19.

Metabolism and pharmacokinetics of aztreonam in healthy subjects.

Swabb EA, Singhvi SM, Leitz MA, Frantz M, Sugerman A.

Antimicrob Agents Chemother. 1983 Sep;24(3):394-400.

20.

Distribution of captopril to foetuses and milk of rats.

Ita CE, Singhvi SM, Heald AF, Migdalof BH.

Xenobiotica. 1982 Oct;12(10):627-32.

PMID:
6760566
21.

Captopril kinetics.

Duchin KL, Singhvi SM, Willard DA, Migdalof BH, McKinstry DN.

Clin Pharmacol Ther. 1982 Apr;31(4):452-8.

PMID:
7037265
22.

Effect of food on the bioavailability of captopril in healthy subjects.

Singhvi SM, McKinstry DN, Shaw JM, Willard DA, Migdalof BH.

J Clin Pharmacol. 1982 Feb-Mar;22(2-3):135-40.

PMID:
7040498
23.

Pharmacokinetics of captopril in dogs and monkeys.

Singhvi SM, Peterson AE, Ross JJ Jr, Shaw JM, Keim GR, Migdalof BH.

J Pharm Sci. 1981 Oct;70(10):1108-12.

PMID:
7028947
24.

Absorption and bioavailability of captopril in mice and rats after administration by gavage and in the diet.

Singhvi SM, Kripalani KJ, Dean AV, Keim GR, Kulesza JS, Meeker FS Jr, Ross JJ Jr, Shaw JM, Migdalof BH.

J Pharm Sci. 1981 Aug;70(8):885-8.

PMID:
7031222
25.

Disposition of captopril in normal subjects.

Kripalani KJ, McKinstry DN, Singhvi SM, Willard DA, Vukovich RA, Migdalof BH.

Clin Pharmacol Ther. 1980 May;27(5):636-41.

PMID:
6989546
26.

Pharmacokinetics of nadolol, a beta-receptor antagonist: administration of therapeutic single- and multiple-dosage regimens to hypertensive patients.

Dreyfuss J, Griffith DL, Singhvi SM, Shaw JM, Ross JJ Jr, Vukovich RA, Willard DA.

J Clin Pharmacol. 1979 Nov-Dec;19(11-12):712-20. No abstract available.

PMID:
43870
27.

Metabolism of tritium- and carbon-14-labeled tiamulin in dogs, rats, and pigs.

Dreyfuss J, Singhvi SM, Shaw JM, Egli P, Ross JJ Jr, Czok R, Nefzger-Biessels M, Battig F, Schuster I, Schmook F.

J Antibiot (Tokyo). 1979 May;32(5):496-503.

28.

Protein binding of drugs.

Heald AF, Singhvi SM.

Ann Clin Lab Sci. 1978 May-Jun;8(3):239-43.

PMID:
655609
29.

Pharmacokinetics of cephalosporin antibiotics: protein-binding considerations.

Singhvi SM, Heald AF, Schreiber EC.

Chemotherapy. 1978;24(3):121-33.

PMID:
657874
30.

Pharmacokinetics of iodamide in normal subjects and in patients with renal impairment.

Difazio LT, Singhvi SM, Heald AF, McKinstry DN, Brosman SA, Gillenwater JY, Willard DA.

J Clin Pharmacol. 1978 Jan;18(1):35-41.

PMID:
338644
31.

Disposition of [14C]nadolol in dogs with reversible renal impairment induced by uranyl nitrate.

Singhvi SM, Heald AF, Murphy BF, DiFazio LT, Schreiber EC, Poutsiaka JW.

Toxicol Appl Pharmacol. 1978 Jan;43(1):99-109. No abstract available.

PMID:
24287
33.

Effect of coadministered salicylamide on terbutaline metabolism in rats.

Singhvi SM, Conway WD, Gibaldi M, Shaar S.

J Pharm Sci. 1977 Oct;66(10):1488-9.

PMID:
925911
34.

Human serum protein binding of cephalosporin antibiotics in vitro.

Singhvi SM, Heald AF, Gadebusch HH, Resnick ME, Difazio LT, Leitz MA.

J Lab Clin Med. 1977 Feb;89(2):414-20.

PMID:
833477
35.

Influence of dose on the metabolism and excretion of terbutaline in the rat.

Singhvi SM, Conway WD, Gibaldi M, Boyes RN.

Xenobiotica. 1974 Sep;4(9):563-70. No abstract available.

PMID:
4432535
36.

The effectof route of administration on the metabolic fate of terbutaline in the rat.

Conway WD, Singhvi SM, Gibaldi M, Boyes RN.

Xenobiotica. 1973 Dec;3(12):813-21. No abstract available.

PMID:
4786682

Supplemental Content

Loading ...
Support Center